199 related articles for article (PubMed ID: 22841556)
1. Development and validation of a ultra high performance liquid chromatography-tandem mass spectrometric method for the direct detection of formoterol in human urine.
Sardela VF; Deventer K; Pereira HM; de Aquino Neto FR; Van Eenoo P
J Pharm Biomed Anal; 2012 Nov; 70():471-5. PubMed ID: 22841556
[TBL] [Abstract][Full Text] [Related]
2. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
[TBL] [Abstract][Full Text] [Related]
3. Quantitative detection of inhaled formoterol in human urine and relevance to doping control analysis.
Deventer K; Pozo OJ; Delbeke FT; Van Eenoo P
Drug Test Anal; 2012 Jun; 4(6):449-54. PubMed ID: 22447497
[TBL] [Abstract][Full Text] [Related]
4. Mass spectrometric detection of peginesatide in human urine in doping control analysis.
Möller I; Thomas A; Delahaut P; Geyer H; Schänzer W; Thevis M
J Pharm Biomed Anal; 2012 Nov; 70():512-7. PubMed ID: 22884786
[TBL] [Abstract][Full Text] [Related]
5. Indacaterol determination in human urine: validation of a liquid-liquid extraction and liquid chromatography-tandem mass spectrometry analytical method.
Ammari WG; Al-Qadhi Z; Khalil M; Tayyem R; Qammaz S; Oriquat G; Basheti IA; Chrystyn H
J Aerosol Med Pulm Drug Deliv; 2015 Jun; 28(3):202-10. PubMed ID: 25229261
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the urinary threshold concentration of formoterol in sports drug testing.
Ventura R; Damasceno LM; Ramírez R; Farré M; Bergés R; Segura J
Drug Test Anal; 2013 Apr; 5(4):266-9. PubMed ID: 23355217
[TBL] [Abstract][Full Text] [Related]
7. Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.
Thomas A; Walpurgis K; Tretzel L; Brinkkötter P; Fichant E; Delahaut P; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):990-8. PubMed ID: 26382721
[TBL] [Abstract][Full Text] [Related]
8. A simplified procedure for the analysis of formoterol in human urine by liquid chromatography-electrospray tandem mass spectrometry: application to the characterization of the metabolic profile and stability of formoterol in urine.
Mazzarino M; de la Torre X; Fiacco I; Pompei C; Calabrese F; Botrè F
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Jul; 931():75-83. PubMed ID: 23777613
[TBL] [Abstract][Full Text] [Related]
9. An improved liquid chromatography-tandem mass spectrometric method to quantify formoterol in human urine.
He G; Lu J; Wang X; Xu Y; Wu Y; Dong Y; Shen L; He Z; Zhao J; Yuan H
J Chromatogr Sci; 2014 Sep; 52(8):848-51. PubMed ID: 24029618
[TBL] [Abstract][Full Text] [Related]
10. Validation of high-performance liquid chromatography assay for quantification of formoterol in urine samples after inhalation using UV detection technique.
Nadarassan DK; Chrystyn H; Clark BJ; Assi KH
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 May; 850(1-2):31-7. PubMed ID: 17126087
[TBL] [Abstract][Full Text] [Related]
11. Ultra-sensitive determination of Formoterol in human serum by high performance liquid chromatography and electrospray tandem mass spectrometry.
Mascher DG; Zech K; Nave R; Kubesch KM; Mascher HJ
J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(1):25-34. PubMed ID: 16275132
[TBL] [Abstract][Full Text] [Related]
12. Analysis of anabolic androgenic steroids as sulfate conjugates using high performance liquid chromatography coupled to tandem mass spectrometry.
Rzeppa S; Heinrich G; Hemmersbach P
Drug Test Anal; 2015; 7(11-12):1030-9. PubMed ID: 26472592
[TBL] [Abstract][Full Text] [Related]
13. Simple quantitation of formoterol and 11-nor-Δ(9)-tetrahydrocannabinol-9-carboxylic acid in human urine by liquid chromatography-tandem mass spectrometry in doping control.
Lee KM; Kim HJ; Son J; Park JH; Kwon OS; Lee J
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Sep; 967():8-12. PubMed ID: 25063922
[TBL] [Abstract][Full Text] [Related]
14. Alternative long-term markers for the detection of methyltestosterone misuse.
Gómez C; Pozo OJ; Marcos J; Segura J; Ventura R
Steroids; 2013 Jan; 78(1):44-52. PubMed ID: 23127819
[TBL] [Abstract][Full Text] [Related]
15. Monitoring 2-phenylethanamine and 2-(3-hydroxyphenyl)acetamide sulfate in doping controls.
Sigmund G; Dib J; Tretzel L; Piper T; Bosse C; Schänzer W; Thevis M
Drug Test Anal; 2015; 7(11-12):1057-62. PubMed ID: 26481102
[TBL] [Abstract][Full Text] [Related]
16. Ultraperformance liquid chromatography tandem mass spectrometric method for direct quantification of salbutamol in urine samples in doping control.
Ventura R; Ramírez R; Monfort N; Segura J
J Pharm Biomed Anal; 2009 Dec; 50(5):886-90. PubMed ID: 19596537
[TBL] [Abstract][Full Text] [Related]
17. Analysis of β-agonists by HPLC/ESI-MS(n) in horse doping control.
Garcia P; Paris AC; Gil J; Popot MA; Bonnaire Y
Biomed Chromatogr; 2011 Jan; 25(1-2):147-54. PubMed ID: 21204111
[TBL] [Abstract][Full Text] [Related]
18. Development of a qualitative liquid chromatography/tandem mass spectrometric method for the detection of narcotics in urine relevant to doping analysis.
Deventer K; Pozo OJ; Van Eenoo P; Delbeke FT
Rapid Commun Mass Spectrom; 2007; 21(18):3015-23. PubMed ID: 17708509
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of GC-EI/MS, GC-EI/MS/MS, LC-ESI/MS/MS, LC-Ag(+) CIS/MS/MS, and GC-ESI/MS/MS for analysis of anabolic steroids in doping control.
Cha E; Kim S; Kim HJ; Lee KM; Kim KH; Kwon OS; Lee J
Drug Test Anal; 2015; 7(11-12):1040-9. PubMed ID: 26489966
[TBL] [Abstract][Full Text] [Related]
20. A fast, comprehensive screening method for doping agents in urine by gas chromatography-triple quadrupole mass spectrometry.
Van Eenoo P; Van Gansbeke W; De Brabanter N; Deventer K; Delbeke FT
J Chromatogr A; 2011 May; 1218(21):3306-16. PubMed ID: 20970803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]